Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease myeloid leukemia
Phenotype C0026986|myelodysplastic syndrome
Sentences 16
PubMedID- 23362656 Azacitidine (5-azacytidine, vidaza) is a disease-modifying agent that improves survival, reduces transfusion dependence, and reduces progression to acute myeloid leukemia in patients with higher risk myelodysplastic syndromes.
PubMedID- 23371544 Secondary acute myeloid leukemia (s-aml) arising from myelodysplastic syndrome (mds) shows different clinical features from de novo aml.
PubMedID- 20377918 Introduction: the development of philadelphia chromosome (ph) negative acute leukemia/myelodysplastic syndrome (mds) in patients with ph-positive chronic myeloid leukemia (cml) is very rare.
PubMedID- 25487075 Preferential occurrence of spliceosome mutations in acute myeloid leukemia with preceding myelodysplastic syndrome and/or myelodysplasia morphology.
PubMedID- 25447656 Bpdcn typically manifests in the skin, but it can also evolve into a leukemic form or be complicated by acute myeloid leukemia, some cases with a preceding myelodysplastic syndrome (mds).
PubMedID- 24808792 St-elevation myocardial infarction and myelodysplastic syndrome with acute myeloid leukemia transformation.
PubMedID- 25323649 Up-front allogeneic hematopoietic cell transplantation in acute myeloid leukemia arising from the myelodysplastic syndrome.
PubMedID- 21425147 Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome.
PubMedID- 23494725 The above scale is poorly correlated with overall survival or transformability into acute myeloid leukemia in patients with secondary myelodysplastic syndromes who constitute a large percentage of patients [44].
PubMedID- 23137720 Clinical prognostic factors for survival and risk of progression to acute myeloid leukemia in patients with myelodysplastic syndromes with < 10% marrow blasts and non-unfavorable cytogenetic categories.
PubMedID- 23240925 Abrupt evolution of philadelphia chromosome-positive acute myeloid leukemia in myelodysplastic syndrome.
PubMedID- 24447728 We assessed the outcomes of 63 patients with acute myeloid leukemia (aml) arising from myelodysplastic syndrome (mds) after hypomethylating agent failure.
PubMedID- 26151071 Dysplastic changes of peripheral eosinophils in acute myeloid leukemia with myelodysplastic syndrome-related features.
PubMedID- 26340093 This meta-analysis, for the first time, combined myelodysplastic syndrome with acute myeloid leukemia to assess the overall risk of adult myeloid disease, and it demonstrated that cigarette smoking is associated with a significantly increased risk of adult myeloid disease.
PubMedID- 21701636 The patient developed myelodysplastic syndrome with acute myeloid leukemia (mds/aml) which was resistant to standard treatments and succumbed to the disease.
PubMedID- 20178141 Dna methyltransferase inhibitors are well tolerated in outpatient settings, with azacitidine prolonging survival and decreasing time to acute myeloid leukemia progression in patients with high-risk myelodysplastic syndromes.

Page: 1